FOCUS: 29 t h SANIBEL CONFERENCE, PEPTIDOMICS: BRIDGING THE GAP BETWEEN PROTEOMICS AND METABOLOMICS BY MS: EDITORIAL AND REVIEW

Editorial and
Peptidomics is the characterization and study of the dynamic peptide complement of a sample and includes the areas of peptide-based biomarker discovery, serum and biological fluid peptide measurements, and neuropeptide/brain peptide characterization. As one critical example, neuropeptides modulate the functioning of every neuron in the brain, affect our mood, and are the targets for drugs of abuse, but surprisingly, many cellcell signaling peptides used in our brain have yet to be characterized.
The conference was successful, with approximately 125 attendees representing over 13 countries ( Fig. 1) participating to discuss the current state-of-the-art technologies and applications in this rapidly evolving field. A total of 46 oral presentations including 28 invited lectures, six shorter Bhot topic^talks, 12 rapid 3-min poster highlight summaries, and 48 poster presentations were given at the conference. ASMS provided 21 travel awards to students and postdocs who presented at the conference. Seven corporate sponsors contributed financial support and demonstrated their newest software and hardware technologies related to peptidomics analysis.
Peptidomics, the study of the peptide complement used in a tissue or organ, is of growing importance, and the rate of peptide discovery is accelerating, with many novel peptides being reported each year. This acceleration is due to striking technological advances in mass spectrometry that enable the peptidome to be characterized from ever smaller samples with ever increasing chemical detail. The conference highlighted both the unique challenges for endogenous peptide detection and the latest technology development and emerging applications in peptidomics, including wide ranging topics from novel sampling strategies, chemical characterization and large-scale peptidome discovery, computational and informatics tools, to therapeutic approaches, spatial mapping, in vivo analysis and the functional study of these intriguing signaling molecules.
Unique to this Sanibel Conference, we had the privilege and distinct pleasure to invite four leaders and pioneers in the field to present keynote lectures throughout the conference (Fig. 2) . The first opening keynote lecture on Thursday evening was delivered by Donald Hunt (University of Virginia) on "Immunotherapy of Cancer and the Role of Mass Spectrometry.Ĥ unt presented a fascinating lecture on their pioneering efforts to apply state-of-the-art MS technology to the field of immunology. Since dysregulation of cell signaling pathways is one of the hallmarks of cancer, Hunt showed strong evidence that MHC phosphopeptides resulting from these pathways are excellent candidates for use in the immunotherapy of cancer. By using sequential affinity isolation, biochemical enrichment, mass spectrometric sequencing, more comprehensive recovery and characterization of phosphopeptides and other PTM peptides can be achieved, which may provide potential new targets for cancer immunotherapy.
The Friday morning program started with a session devoted to discussions and presentations on unique challenges for measurement of endogenous peptides' spanning sequence analysis, peptide stability and discovery. The session began by a presentation by Robert Kennedy (University of Michigan) on "Observation of Peptide Dynamics In Vivo Evoked by Behavior and Optogenetic Stimulation using LC-MS.^Kennedy discussed the challenges for in vivo neurochemical monitoring and presented strategies and progress on improving peptide recovery rate via microdialysis sampling. Applications in neurochemistry of motivation and feeding behavior using rodent model systems were highlighted. Following this talk was a presentation by Kurt Boonen (KU Leuven) on "Peptidomics in Neuroendocrine Research^where invertebrate model organisms including tsetse fly and Caenorhabditis elegans were utilized for peptidomic analysis. Boonen presented an overview of a peptidomics approach where LC-MS is combined with in silico mining of neuropeptide precursor sequences. Using this approach, the group was able to identify an unprecedented number of 203 mature neuropeptides from C. elegans whole-body extracts, thus creating a useful resource for the peptidomics community. The session ended with a presentation by Lingjun Li (University of Wisconsin) on the "Multi-faceted Approach for Functional Discovery of Neuropeptides" where she discussed the challenges for neuropeptide discovery from model organisms that lack of a fully sequenced genome and strategies to improve de novo sequencing of neuropeptides. Li presented their recent progress on the development of mass spectral imaging, affinity-enhanced microdialysis, and isotopic labeling strategies for comparative peptidomic analysis in feeding. Several on-going studies with rodent model system and multiplex quantitation enabled by high-resolution MS and dimethylated leucine (DiLeu) tags were also highlighted.
The second session in the morning focused on informatics for peptidome discovery. Nuno Banderia (UC San Diego) delivered a presentation entitled BSpectral Networks for De Novo Sequencing.^In contrast to traditional spectrum identification algorithms that analyze each tandem mass spectrum in isolation, spectral networks define a new computational approach that finds and simultaneously interprets sets of spectra from overlapping peptides. Banderia presented the evolutionary development of multiple versions of de novo sequencing programs based on this new approach. A key aspect of this approach is to recognize variants in similar peptide sequences, which facilitates the characterization of modified peptides and peptide and protein isoforms. Following this, Andrew Christie (University of Hawaii) spoke on BIn Silico Prediction of Crustacean Peptidome^where he presented strategies for combining MS accurate mass matching and de novo sequencing with in silico genome and transcriptome mining for accelerated neuropeptide discovery in crustacean model organisms. Tissue-specific de novo assembled transcriptomes can be mined to allow in silico prediction of neuropeptides followed by MS confirmation. The final presentation in this session was given by Marshall Bern (Protein Metrics) on BBacterial Peptidoglycan Analysis using a Proteomics Search Engine^. He presented the use of bottom-up proteomics methods by high-resolution MS and automated analysis of HCD and ETD fragmentation spectra with Byonic software for a systematic and detailed structural analysis of peptidoglycans in bacteria.
Following the intensive morning sessions of scientific presentations, the conference attendees enjoyed a nice group lunch together sponsored by ASMS in a relaxed setting and continued stimulating discussions (Fig. 3) . The afternoon talks featured presentations on BPeptide Processing and Post-Translational Modifications.^Vivian Hook (UC San Diego) presented an informative lecture on BFrontiers in Neuropeptidomic Profiling of Intercellular Signaling Networks in Human Health and Disease.^She began with an overview of neuropeptide diversity and their production through pro-neuropeptide precursor proteolytic processing and covalent modifications, followed by a discussion about current challenges in neuropeptide identification and MS and informatics strategies to overcome some of the limitations. Hook focused her discussions on human-specific cathepsins and their roles in neuropeptide production and secretion in healthy and disease conditions. She also presented some interesting perspectives on the use of peptidomics approaches to probe peptide signaling mechanisms in human cellular models of patient-derived induced pluripotent stem cell (iPSC) neurons to recapitulate and study human disease in a dish. Lloyd Fricker (Albert Einstein School of Medicine) delivered a talk on BQuantitative Peptidomics of Yeast, Mouse, and Human Cellsŵ here he presented an overview of the peptidomics workflow with special emphasis on sample preparation such as microwave irradiation and other denaturing methods to rapidly deactivate protease activity for improved endogenous peptide detection. Fricker reported on several quantitative schemes including a 5-plex formaldehyde labeling strategy using different isotopic forms of formaldehyde and cyanoborohydride reagents and their application to comparative peptidomic analysis of human cell lines, yeast, and mouse samples. The other two presentations in this session focused on MS characterization of peptides with posttranslational modifications (PTMs). Perhaps one of the most unique and challenging PTMs for MS identification is the isomerization of an L-to D-amino acid resulting in no mass shift for this PTM. James Checco (University of Illinois) presented an exciting talk on BMS Characterization of D-amino acid-containing Peptides (DAACPs).^He introduced a threestep funnel approach consisting of screening, chiral analysis, and confirmation with synthetic standards that enabled nontargeted discovery of DAACPs from sea slug Aplysia californica and demonstrated their role in feeding. Another peptide PTM characterization talk was given by Beatrix Ueberheide (New York University) on BUncovering Disulfide-Rich Peptide Venoms Using Chemical Derivatization and ETD.^Ueberheide presented an integrated workflow to discover neurologically active peptides from venom using a combination of chemical derivatization, CID/ETD, de novo sequencing, and Byonic software and other database search tools.
After a few hours' break and relaxing time to explore the beautiful Clearwater Beach in the afternoon, the evening session featured the second keynote lecture by Dominic Desiderio (University of Tennessee) on BPeptidomics Research Before It Was Called Peptidomics.^Widely regarded as one of the pioneers who worked on neuropeptide analysis by mass spectrometry, Desiderio gave a historical overview of the field of neuropeptide discovery, characterization, and evolutionary role of MS to accelerate these discoveries. Both qualitative and quantitative analytical strategies were discussed with special emphasis on opioid neuropeptides in human pituitary tissues. Comparative peptidomics and proteomics enabled better elucidation of molecular mechanisms involved in tumor formation as defects in neuropeptidergic system processing is a contributing factor to human anterior pituitary tumor formation. The keynote lecture was followed by six 3-min highlighted poster presentations given by Bruce Southey (University of Illinois; BA bioinformatics pipeline for genome sequence-based characterization of neuropeptidomes^), Matt Baird (Wichita State University; (Fig. 3) .
Saturday morning started with a session focused on BPeptide Imaging Using Mass Spectrometry.^Per Andrén (Uppsala University) presented a talk on BSample Handling, Quantification and Imaging of Brain Signaling Molecules.^Andrén discussed the utility of focused heat stabilization for enhanced detection of neuropeptides, and presented MALDI MS imaging of neuropeptides and small molecule neurotransmitters where novel derivatization agents and reactive matrices were developed to enable simultaneous imaging of multiple neurotransmitters. Isotopeincorporated matrix was used to obtain relative quantitation information The second morning session on Saturday featured presentations on BEmerging Tools and Applications.^Carlito Lebrilla (UC Davis) presented a talk on BPeptidomic and Glycopeptidomic Analysis of Bioactive Compounds in Human Milk.^The Lebrilla group has performed extensive MS analysis of the human milk peptidome to reveal thousands of endogenous peptides produced by specific enzymatic cleavages. In-house computational tools were developed to visualize and interpret the data through estimation of the differential enzyme participation. Lebrilla also highlighted recent applications of ion mobility spectrometry (IMS) to screen for different activities as reflected by multiple conformations and PTMs on these milk peptides.
Jay Forsythe (College of Charleston) delivered a presentation entitled BProto-Peptidomics: The First Peptides in Darwin's Warm Little Pond,^where he presented a fascinating story of using LC-MS tools to unravel high sequence diversity of protopeptides. Using a dry-wet environmental cycling protocol, hundreds of proto-peptide sequences containing broader combinations of prebiotically plausible monomers were formed over a few day's reaction. The MS-based sequencing and database searching approach presented by Forsythe could be a powerful tool as the origins-of-life research moves toward systems-level investigations of prebiotic chemistry. David Clemmer (Indiana University, BDeveloping IMS-MS Techniques for Following Structural Transitions in Peptides in Solution and in Gas Phase^) showed the use of advanced IMS instrumentation to capture intermediate states of peptide and protein ions in the gas phase as they switch between different conformations. Detailed intermediate steps and molecular insights can be gained from measuring collision cross-section distributions of various intermediate structures and performing molecular dynamic simulations. Four model systems including polyproline-13, two neuropeptides, bradykinin and substance P, and a small protein ubiquitin were discussed to demonstrate the utility of this approach. The morning session ended with a short talk by Ryan Julian (UC Riverside) who presented on BIdentifying Isomerization and Epimerization in Peptides from Crystallins with Radical Directed Dissociation.^Julian introduced the use of radical directed dissociation (RDD), a gas phase radical-based dissociation method via site-specific photodissociation, to distinguish peptide epimers based on fragmentation patterns and identify four Asp isomers generated via deamidation using LC-MS/MS. Using this method, Julian and his team identified numerous peptide isomerization and epimerization in long-lived crystalline proteins, including some unexpected isomerization sites that might reveal novel molecular insights into aging.
The Saturday afternoon session focused on Peptide Therapeutics. Wendy Zhong (Merck Co.) discussed BChallenges in Structure Determination of Low Level Impurity and Degradation Products of Therapeutic Peptides in Pharmaceutical Industry.Ŝ he presented several case studies on the use of electron activated dissociation (ExD) to differentiate isomeric amino acid residues and the combined use of ExD and CAD to determine unknown impurities in a large peptide, which is relevant to the comprehensive characterization of impurities generated from therapeutic peptide synthesis. Albert Lebedev (Moscow State University) presented on BDiscovery of New Antibiotics from Frogs -De Novo Sequencing of Long Natural Non-Tryptic Peptides^where he discussed strategies of employing hybrid electron-transfer high-energy collision induced dissociation (EThcD) to discriminate isomeric leucine/isoleucine residues in peptides. The utility of this approach was demonstrated by de novo sequencing of large intact frog skin peptides with intramolecular disulfide loops in a complex mixture of natural non-tryptic peptides. (Fig. 3) .
The final half day of the conference on Sunday morning started with a session on BPeptidomic Approaches to Biomarker Discovery and New MS Strategies for Peptide Analysis^. Johan Gobom (University of Gothenburg) delivered a presentation on BPeptide Biomarkers in Neurodegenerative Diseases.^He presented a quantification-driven workflow that relied on spectral clustering to match MS/MS spectra. Multiplex isobaric labeling was employed to analyze endopeptidomes of cerebrospinal fluid from patients at different disease stages (and controls) to allow biomarker discovery. Complementary to the use of biofluid for biomarker discovery, Richard Drake (Medical University of South Carolina) focused his biomarker discovery from clinical tissue samples. His talk on BProstate Cancer-associated Peptide and Glycan Co-localization in FFPE Tissues by MALDI-FTICR Imaging Mass Spectrometry^highlighted strategies to map the spatial distribution and co-localization patterns of N-linked glycan distributions and tryptic peptides in fresh frozen tissues and formalin-fixed paraffin-embedded tissues where tumor-specific glycans can be grouped relative to nontumor regions.
The last talk of this session was given by Francisco Fernández-Lima (Florida International University) where he discussed "Strategies for Discovery and Targeted Analysis using nESI-TIMS-TOF MS and nESI-TIMS-FTICR MS." Fernández-Lima in collaboration with the Pacific Northwest National Laboratory (Richland, WA) team evaluated the potential of trapped ion mobility spectrometry (TIMS) coupled to TOF MS for discovery and targeted monitoring of peptide biomarkers from human-in-mouse xenograft tumor tissue. Equipped with high mobility resolution (R = 150-250), the offline nanoESI-TIMS-CID-TOF MS was shown to be complementary to the traditional LC-ESI-MS/MS proteomics workflow.
The second session of the Sunday morning featured presentations on "Single-cell Neuropeptidomics.^Susanne Neupert (University of Cologne) presented work on "Single Cell Peptidomics in Insects.^She showed impressive results for mapping neuropeptide expression from single neurons in a variety of insect species, including cockroaches and fruitflies. N-terminal derivatization using 4-sulfophenyl isothiocyanate and subsequent MS analysis was demonstrated for de novo sequencing of neuropeptides from single cells. Complementary to fruitfly single-cell peptidomic analysis, Tony Stretton (UW-Madison) presented his work on MS mapping of neuropeptides in the nematode Ascaris sum. Stretton reported on the use of three independent techniques, single-cell MS, in conjunction with immunocytochemistry, and in situ hybridization, to localize neuropeptides and their transcripts in the nervous system of A. suum. Using this combined approach, they were able to discover novel neuropeptides in four GABAergic neurons involved in a three-dimensional head movement of the worm. The final presentation of this session was delivered by Peter Nemes (George Washington University) on the topic of BTrace-level Metabolite-Peptide-Protein Detection in Single Cells using High-Resolution MS.^Using the frog Xenopus laevis as a model system, Nemes demonstrated enhanced peptide detection toward single-neuron proteomics by supplementing ultrasensitive capillary electrophoresis (CE)-nanoESI-high-resolution MS with reversed-phase fractionation.
The conference ended with the final keynote lecture that was presented by Jonathan Sweedler (University of Illinois) on BMeasuring Signaling Peptides One Cell at a Time.^Sweedler has focused on the development of new metabolomics and peptidomics technologies for assaying small volume samples, and application of these methods to study novel neurochemistry. He highlighted several neuropeptidomic studies from a range of model organisms spanning from mollusks, insects to mammals, using a suite of ultrasensitive mass spectrometry measurement tools. Recent examples of high throughput mapping of single cell heterogeneity of islets via microscopyguided single-cell MALDI MS were demonstrated.
This Special Focus Issue features developments and applications related to the topic of BMS-based Peptidomics,^and the articles are contributed by those who presented their work at the 29th Sanibel Conference on Peptidomics, and include the following:
